This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Glucose and Sodium Chloride

Read time: 1 mins
Marketing start date: 05 Apr 2025
...
 

Summary of product characteristics


Effective Time

20241121

Version

2

Spl Product Data Elements

Glucose and Sodium Chloride Dextrose Anhydrous and Sodium Chloride DEXTROSE MONOHYDRATE ANHYDROUS DEXTROSE SODIUM CHLORIDE SODIUM CATION CHLORIDE ION WATER

Brand Name

Glucose and Sodium Chloride

Generic Name

Dextrose Anhydrous and Sodium Chloride

Product Ndc

0338-9799

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Baxter Logo Trademark A6C1064US GLUCOSE AND SODIUM CHLORIDE INJECTION 100 200 300 400 500 600 700 800 900 1000ml 5% GLUCOSE 0.9% SODIUM CHLORIDE [Strength] 1000ml: glucose 50g and sodium chloride 9g [Description] This product is a clear, colorless liquid [Dosage and Administration] Intravenous drip See the package insert for details For details of [Indications], [Adverse Reactions], [Contraindications], and [Precautions], please refer to the package insert [Storage] Store in overwrap The solution should be clear and should be used up at one time Inspect the inner bag by squeezing it and discard solution if leakage occurs License Number: H19994068 AA [Drug Marketing Authorization Holder] [Manufacturer] Name: Baxter Healthcare (Shanghai) Co., Ltd. Address: No. 388, Tingzhu Road, Jinshan District, Shanghai BarCode (01) 00303389799016 LOT MFG EXP 5% Glucose/0.9% Sodium Chloride Injection 1000ml X 12 LOT S0000000 EXP YYYY-MM A6C1064US 1C/N LIC H19994068 5% Glucose/0.9% Sodium Chloride Injection 1000ml X 12 LOT S0000000 EXP YYYY-MM MFG YYYY-MM-DD 1C/N 0000 A6C1064US Representative Carton Label 1 A6C1064US Representative Carton Label 2.jpg

Spl Unclassified Section

PACKAGE INSERT SPC304US Image 1.jpg SPC304US Image 2.jpg SPC304US Image 3.jpg SPC304US Image 4.jpg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.